It is clear from SQSTM1 and GBA that the age of onset and phenotype severity are related to the genetic burden, with homozygous mutations causing rare childhood-onset neurodegenerative syndromes while heterozygous mutations are associated with more common late-onset neurodegenerative disorders such as ALS and PD. This evidence concerns the gene SQSTM1 and Parkinson disease.